Discovery of a high potent PIM kinase inhibitor for acute myeloid leukemia based on N-pyridinyl amide scaffold by optimizing the fragments toward to Lys67 and Asp128/Glu171-Reference-Cited by-同舟云学术

Discovery of a high potent PIM kinase inhibitor for acute myeloid leukemia based on N-pyridinyl amide scaffold by optimizing the fragments toward to Lys67 and Asp128/Glu171

Published:2023-09 Issue: Volume:257 Page:115514
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Xiang Ruiqing,Lu Mingzhu,Wu Tianze,Yang Chengbin,Jia Yu,Liu Xiaofeng,Deng Mingli,Ge Yu,Xu Jun,Cai Tong,Ling Yun,Zhou Yaming^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference32 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022

2. Acute myeloid leukemia, version 3.2019, NCCN clinical practice guidelines in oncology;Tallman;J. Natl. Compr. Cancer Netw.,2019

3. Updates on targeted therapies for acute myeloid leukaemia;Kayser;Br. J. Haematol.,2022

4. Novel therapies in chronic lymphocytic leukemia: a rapidly changing landscape;Iovino;Curr. Treat. Options Oncol.,2020

5. Pim kinase inhibitors in cancer: medicinal chemistry insights into their activity and selectivity;Alnabulsi;Drug Discov. Today,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancer;Molecular Diversity;2024-04-20

2. Comprehensive Insights that Targeting PIM for Cancer Therapy: Prospects and Obstacles;Journal of Medicinal Chemistry;2024-01-02